Moods Disorders Completed Phase 4 Trials for Mirtazapine (DB00370)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00288782PET Neuroimaging of [11C]MirtazapineDiagnostic